Acurx Pharmaceuticals (ACXP) Misses Q3 EPS by 2c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q3 EPS of ($0.17), $0.02 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• Kalshi in early talks for IPO - The Information
• Accenture tumbles 16% on guidance cut; announces Dragos, runZero, NetRise deals
• Grizzly Discoveries closes private placement raising $349,044